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INTRODUCTION 
The NASA Integrated Medical Model (IMM) assesses the risk, including likelihood and impact of occurrence, of all 
credible in-flight medical conditions. Fatigue due to sleep disruption is a condition that could lead to operational 
errors, potentially resulting in loss of mission or crew. Pharmacological consumables are mitigation strategies used 
to manage the risks associated with sleep deficits. The likelihood of medical intervention due to sleep disruption was 
estimated with a well validated sleep model and a Monte Carlo computer simulation in an effort to optimize the 
quantity of consumables. 
METHODS 
The key components of the model are the mission parameter program, the calculation of sleep intensity and the 
diagnosis and decision module. The mission parameter program was used to create simulated daily sleep/wake 
schedules for an ISS increment. The hypothetical schedules included critical events such as dockings and 
extravehicular activities and included actual sleep time and sleep quality. The schedules were used as inputs to the 
Sleep, Activity, Fatigue and Task Effectiveness (SAFTE) Model (IBR Inc., Baltimore MD), which calculated sleep 
intensity. Sleep data from an ISS study was used to relate calculated sleep intensity to the probability of sleep 
medication use, using a generalized linear model for binomial regression. A human yes/no decision process using a 
binomial random number was also factored into sleep medication use probability. 
RESULTS 
These probability calculations were repeated 5000 times resulting in an estimate of the most likely amount of sleep 
aids used during an ISS mission and a 95% confidence interval. 
CONCLUSIONS 
These results were transferred to the parent IMM for further weighting and integration with other medical 
conditions, to help inform operational decisions. This model is a potential planning tool for ensuring adequate sleep 
during sleep disrupted periods of a mission. 
https://ntrs.nasa.gov/search.jsp?R=20110011356 2019-08-30T15:27:37+00:00Z
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NASA’s Integrated Medical Model
 A probabilistic, simulation-based tool used to predict the rate of occurrence of in-flight 
medical events 
 Used to help determine the relative risk of medical events that could occur in space
 Used to help optimize mitigation tools, such as the in flight medical kit
 Probabilistic risk assessment methods are utilized in combination with the best available 
spaceflight data , evidence and relevant terrestrial databases
Sleep & Performance Metrics
• The Sleep, Activity, Fatigue and Task Effectiveness (SAFTE) Model is an accepted sleep model used to 
determine the effects of sleep timing and duration and the influence of time of day (circadian effects)
• SAFTE accurately reflects the degrading effects of sleep fragmentation or sleep interruptions
• SAFTE input is mission schedule and astronaut parameters
• SAFTE output is effectiveness, sleep reservoir and sleep intensity
BACKGROUND METHODS (Con’t)
SLEEP 
REGULATION
CIRCADIAN OSCILLATORS DYNAMICPHASE
PERFORMANCE
MODULATION
12
96
98
100
1.6
1.8
2
Effectiveness
Sleep Intensity Awake
07:00 23:00
Sleep Disruption on the International Space Station (ISS)
 Difficulties with sleep affect more than half of all US crews on ISS
 Mitigation strategies of sleep disruption impact the mass and volume of vehicle 
consumables and the mission timeline
 The SDMIF tool estimates the occurrence of sleep disruption and need for medical 
interventions
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Sleep Metric and Sleep Aid Use
•The underlying premise was that below a particular sleep intensity threshold, pharmaceutical intervention is likely
•A logistic regression was used to correlate sleep intensity calculated with SAFTE to reported incidences of 
intervention, obtained from the Sleep-Wake Actigraphy and Light Exposure During Spaceflight study (NCC9-119, 
The Sleep Activity, Fatigue, and Task Effectiveness 
(SAFTETM) Model (IBR, Inc)
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•The regression coefficients were used in the model equation that translated sleep intensity to probability 
•A human yes/no decision process was also incorporated with a binomial random number
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Mission Work and Sleep Timelines
• Generated realistic ISS mission schedules of sleep and wake times derived from historical planned and 
actual ISS mission schedules
• The sleep/wake schedules included shifting events: Shuttle, Soyuz and Progress Dockings and Extra 
Vehicular Activities (EVA)
• The actual amount of sleep obtained during a sleep opportunity was predicted 
• The quality of sleep, dependent on the frequency and quantity of wakefulness, or interruptions was 
modeled
Estimated Number of Sleep Aids Used During 
an ISS Mission
• Estimate based on 5000 trials
• Result was 13 ± 5.5 (mean ± standard deviation) 
sleep aids per mission with a 95% confidence 
interval of 4 – 25
METHODS
RESULTS
Logistic regression of SAFTE output with data 
from NRA NCC9-119
  
Model Limitations
• Mission work and sleep timelines were based on 
ISS increments 1 – 12. The average number of 
data points in each parameter distribution was 10 
± 7, which is a fairly small sample, accuracy 
could be improved with additional data from 
additional increments. 
DISCUSSION
Graphical example of a sleep/wake schedule for a simulated ISS mission. Black areas represent 
wakefulness, white areas represent sleep opportunities.
• The sleep intensity threshold was found using 
SAFTE model values of sleep intensity, which is a 
calculated, rather than physiological measure.
• The p-value of the logistic regression used to 
find the sleep intensity threshold was 0.6427 
indicating that the model fit is no better than when 
a fixed response rate across the whole sample is 
used.
• The above result highlights that medication use 
may be a multi-factor problem and that the model 
may not capture environmental and physiological 
factors that are major factors in medication use
•S R Hursh et al "Fatigue models for applied research in warfighting " Aviat Space Environ Med vol 75 no 3 Suppl p A44-A53 Mar 2004
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Results showing number of sleep meds 
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• Future models should attempt to utilize a sleep 
model more tailored to space flight conditions.
• Future estimates of sleep intensity, used to 
perform the correlation with flight data, should 
use the actual sleep structure over the length of 
the ISS increment.
Soyuz event
(A) STS slam shift event, (B) STS gradual shift event (A) EVA slam shift event, (B) EVA gradual shift event 
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(A) Progress slam shift event, (B) Progress gradual shift event 
This work is funded by the NASA Human Research Program, managed by the NASA Johnson Space 
Center. Specifically, the work is part of the Integrated Medical Model, which is part of the Exploration 
Medical Capability Element
ACKNOWLEDGEMENTS
